I do have to say, the more I look into this, the more concerned I am that GTEC has been intertwined with Subway. Gold horse, Lotus...Part of these companies promotions include posting on message boards, I wonder if anyone here is courteous of Subway?
I guess if there is anything good to make of the below excerpt, its that they thought enough of GTEC to buy shares on the open market. Its interesting that an officer of CRG is essentially a partner with GTEC to "consult" Lotus.
I will keep buying GTEC but I think I'll diversify into other Chinese pharm too, since i am definately bullish on the industry over there.
********************From Subway
Genesis Pharmaceuticals Enterprises Inc. - CRGP has been compensated one hundred thousand restricted LTUS shares for GTEC. For promotional work prior to the licensing of TheSUBWAY to CRGP, CRG was compensated five million four hundred thousand restricted shares of Genesis Technology Group Inc. (GTEC). CRG also received six hundred thousand common shares of GTEC, and additional compensation of ten thousand dollars. CRG also purchased three hundred ten thousand GTEC shares in the open market. CRG has sold GTEC shares, and intends to continue to sell its shares and to purchase and sell additional shares of GTEC. An officer of CRG is the sole owner of a limited liability company (the LLC) that is a member of and owns 25 percent of Genesis Equity Partners (GEP) a limited liability company of which GTEC is a member and owns a fifty one percent interest. GEP is a general partner in a partnership agreement with Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) hereafter Lotus, a publicly traded company, whereby GEP for a period of 18 months is a non exclusive external consultant in connection with financial and related matters. Under that partnership agreement the members of GEP received Lotus stock; the LLC owned by an officer of CRG received 3,302,400 shares of Lotus stock. The LLC intends to sell its shares of Lotus. GEP also receives a fee of $10,000 per month from Lotus. CRGP intends to sell its shares. CRGP has sold approximately zero LTUS or GTEC shares to date.
Gold Horse International Inc. - CRGP has been compensated two hundred thousand restricted shares for SPEH. For promotional work prior to the licensing of TheSUBWAY to CRGP, CRG was compensated five million four hundred thousand restricted shares of Genesis Technology Group Inc. (GTEC). CRG also received six hundred thousand common shares of GTEC, and additional compensation of ten thousand dollars. CRG also purchased three hundred ten thousand GTEC shares in the open market. CRG has sold GTEC shares, and intends to continue to sell its shares and to purchase and sell additional shares of GTEC. An officer of CRG is the sole owner of a limited liability company (the LLC) that is a member of and owns 25 percent of Genesis Equity Partners (GEP) a limited liability company of which GTEC is a member and owns a fifty one percent interest. GEP is a general partner in a partnership agreement with Gold Horse International, Inc. (OTCBB:SPEH) hereafter SPEH, a publicly traded company, whereby GEP for a period of 18 months is a non exclusive external consultant in connection with financial and related matters. Under that partnership agreement the members of GEP received SPEH stock; the LLC owned by an officer of CRG has received 837,500 shares of SPEH stock. The LLC intends to sell its shares of SPEH. GEP also receives a fee of $10,000 per month from SPEH. CRGP intends to sell its shares. CRGP has sold approximately zero SPEH shares to date.
Lotus Pharmaceuticals Inc. - CRGP has been compensated one hundred thousand restricted shares for LTUS. For promotional work prior to the licensing of TheSUBWAY to CRGP, CRG was compensated five million four hundred thousand restricted shares of Genesis Technology Group Inc. (GTEC). CRG also received six hundred thousand common shares of GTEC, and additional compensation of ten thousand dollars. CRG also purchased three hundred ten thousand GTEC shares in the open market. CRG has sold GTEC shares, and intends to continue to sell its shares and to purchase and sell additional shares of GTEC. An officer of CRG is the sole owner of a limited liability company (the LLC) that is a member of and owns 25 percent of Genesis Equity Partners (GEP) a limited liability company of which GTEC is a member and owns a fifty one percent interest. GEP is a general partner in a partnership agreement with Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) hereafter Lotus, a publicly traded company, whereby GEP for a period of 18 months is a non exclusive external consultant in connection with financial and related matters. Under that partnership agreement the members of GEP received Lotus stock; the LLC owned by an officer of CRG received 3,302,400 shares of Lotus stock. The LLC intends to sell its shares of Lotus. GEP also receives a fee of $10,000 per month from Lotus. CRGP intends to sell its shares. CRGP has sold approximately zero LTUS shares to date.
